SUNIL AGARWAL

Insider Reports History

Location
Novato, CA
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Sunil Agarwal
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by SUNIL AGARWAL:

Company Role Class Num Shares Value Price $ Report Date Ownership
ARVINAS, INC. Director Common Stock 30,166 $195,174 $6.47 25 Jun 2025 Direct
ARVINAS, INC. Director Stock Option (right to buy) 23,105 $145,120 $16.00 25 Jun 2025 Direct
Sana Biotechnology, Inc. EVP, Head of Development & CMO Stock Options (Right to Buy) 250,000 03 Mar 2022 Direct
Calithera Biosciences, Inc. Director Stock Option (Right to Buy) 20,000 01 Jun 2022 Direct
Astria Therapeutics, Inc. Director Stock Option (Right to Buy) 0 23 Jan 2026 Direct

Insider Reports Filed by SUNIL AGARWAL

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATXS Astria Therapeutics, Inc. 23 Jan 2026 2 $0 4 Director 23 Jan 2026, 16:15
ARVN ARVINAS, INC. 25 Jun 2025 2 $0 4 Director 30 Jun 2025, 06:14
ATXS Astria Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 12 Jun 2025, 19:16
ARVN ARVINAS, INC. 29 May 2024 2 $0 4 Director 31 May 2024, 17:52
ATXS Astria Therapeutics, Inc. 08 Apr 2024 1 $0 4 Director 09 Apr 2024, 08:11
ATXS Astria Therapeutics, Inc. 05 Apr 2024 0 $0 3 Director 09 Apr 2024, 08:09
ARVN ARVINAS, INC. 15 Jun 2023 2 $0 4 Director 20 Jun 2023, 17:25
ARVN ARVINAS, INC. 15 Jun 2023 0 $0 3 Director 20 Jun 2023, 17:24
/report/000089924322020933-agarwal-sunil-2022-06-01 Calithera Biosciences, Inc. 01 Jun 2022 1 $0 4 Director 03 Jun 2022, 16:05
SANA Sana Biotechnology, Inc. 03 Mar 2022 1 $0 4 EVP, Head of Development & CMO 08 Mar 2022, 08:07
SANA Sana Biotechnology, Inc. 15 Sep 2021 2 -$1,564,057 4 EVP, Head of Development & CMO 17 Sep 2021, 16:27
/report/000089924321023535-agarwal-sunil-2021-06-11 Calithera Biosciences, Inc. 11 Jun 2021 1 $0 4 Director 14 Jun 2021, 16:05